Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Benzamide vasopressin antagonists in the Fujisawa pipeline

Feb. 8, 2001

Nonpeptide IL-2 production inhibitors and their use reported by Shionogi

Feb. 8, 2001

Selective or nonselective ET antagonists for pulmonary hypertension?

Feb. 8, 2001

Collgard and Mayo Clinic sign second agreement for halofuginone development

Feb. 8, 2001

FDA extends approval of Toprol-XL to include heart failure

Feb. 7, 2001

TCV-309 improves organ dysfunction and morbidity, but not mortality, in septic shock

Feb. 7, 2001

Orion claims new use for levosimendan

Feb. 6, 2001

MAA for UT-15 filed in France; new name accepted

Feb. 6, 2001

Sustained beneficial effects seen for ALT-711 on arterial and ventricular parameters in aged monkeys

Feb. 6, 2001

Bispidine antiarrhythmic agents from AstraZeneca

Feb. 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...